MDGL, WW and AKBA are among pre market gainers

seekingalpha
15 Mar 2024
  • Gainers: Geron (GERN) +71% wins FDA AdCom backing for blood cancer drug.
  • Cardlytics (CDLX) +48% Q4 earnings call release
  • Madrigal Pharmaceuticals (MDGL) +25% granted FDA approval for NASH therapy.
  • AtlasClear Holdings (ATCH) +16%.
  • Akebia Therapeutics (AKBA) +16%.
  • RLX Technology (RLX) +9%.
  • WW International (WW) +7%.
  • Spectral (MDAI) +7%.
  • Groupon (GRPN) +6%.
  • PowerFleet (PWFL) +6%.
  • Acacia Research (ACTG) +6%.

More on pre market gainers & stock

  • I Worry That WW International, Formerly Weight Watchers, May Not Survive
  • WW International, Inc. (WW) Q4 2023 Earnings Call Transcript
  • Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown
  • Biggest stock movers today: ADBE, GERN, and more
  • WW expects to beat previously given Q1 subscriber guidance

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10